- Home
- TPST vs CLNN Comparison
TPST vs CLNN Comparison
Compare TPST & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPST
- CLNN
- Stock Information
- Founded
- TPST 2011
- CLNN 2012
- Country
- TPST United States
- CLNN United States
- Employees
- TPST N/A
- CLNN N/A
- Industry
- TPST Biotechnology: Pharmaceutical Preparations
- CLNN Biotechnology: Pharmaceutical Preparations
- Sector
- TPST Health Care
- CLNN Health Care
- Exchange
- TPST Nasdaq
- CLNN Nasdaq
- Market Cap
- TPST 40.4M
- CLNN 37.7M
- IPO Year
- TPST N/A
- CLNN N/A
- Fundamental
- Price
- TPST $0.86
- CLNN $4.43
- Analyst Decision
- TPST Strong Buy
- CLNN Strong Buy
- Analyst Count
- TPST 3
- CLNN 4
- Target Price
- TPST $21.67
- CLNN $55.25
- AVG Volume (30 Days)
- TPST 877.6K
- CLNN 47.6K
- Earning Date
- TPST 03-18-2025
- CLNN 03-12-2025
- Dividend Yield
- TPST N/A
- CLNN N/A
- EPS Growth
- TPST N/A
- CLNN N/A
- EPS
- TPST N/A
- CLNN N/A
- Revenue
- TPST N/A
- CLNN $421,000.00
- Revenue This Year
- TPST N/A
- CLNN N/A
- Revenue Next Year
- TPST N/A
- CLNN N/A
- P/E Ratio
- TPST N/A
- CLNN N/A
- Revenue Growth
- TPST N/A
- CLNN N/A
- 52 Week Low
- TPST $0.70
- CLNN $3.82
- 52 Week High
- TPST $6.00
- CLNN $10.40
- Technical
- Relative Strength Index (RSI)
- TPST 40.89
- CLNN 42.58
- Support Level
- TPST $0.85
- CLNN $4.15
- Resistance Level
- TPST $0.95
- CLNN $4.99
- Average True Range (ATR)
- TPST 0.05
- CLNN 0.28
- MACD
- TPST -0.00
- CLNN 0.00
- Stochastic Oscillator
- TPST 9.45
- CLNN 33.33
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements).